9 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.
R. C. Patel Institute of Pharmaceutical Education and Research
Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.
University of Ljubljana
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
UniversitäT TüBingen
Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria.
Experimental Therapeutics Centre
Synthesis and antimycobacterial activity of 1-(β-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole.
University of Delhi
New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity.
University of Ljubljana
Linker-switch approach towards new ATP binding site inhibitors of DNA gyrase B.
University of Ljubljana
Bacterial topoisomerase I inhibitors with antibacterial activity
The Florida International University Board of Trustees